Arthrex reportedly paid a physician to use the company’s orthopedic products. Separately, multiple telehealth-related false-billing schemes landed six men in hot water.
Arthrex, Inc. has agreed to pay $16m to resolve allegations the device maker violated anti-kickback law. It’s the highest-profile of several medtech-related cases in which the US Department of Justice (DOJ) announced resolutions this week.
The DOJ says Arthrex violated the False Claims Act by paying a Colorado-based orthopedic surgeon to use the company’s SutureBridge and SpeedBridge kits, thereby causing fraudulent claims to be submitted...
The UK has issued clearer guidance to help drug and medical device sponsors demonstrate how they intend to include a diverse and relevant range of participants in their clinical trials.
Moves are at last underway for a more specific focus on orphan and pediatric devices. They are a start; but experts are calling for more to support this sector.
Fujirebio Diagnostics' Alzheimer's disease test, Lumipulse G pTau217/ß-Amyloid 1-42 Plasma Ratio, has been cleared by the US FDA.
